56th Annual Irish Neurological Association Meeting Programme
Programme
Thursday October 1st
12.30 Log-in to virtual INA meeting via IICN website link
12.45 Opening and Welcome to First virtual INA Meeting – Professor Tim Lynch, INA President 2020
13.00 Session I- Multiple Sclerosis
14.00 Session II – Epilepsy
15.40 Session III – Virtual Poster Tour I
16.00 Session IV – Cognition and Neurodegeration
17.00 Session V – Irish Neurological Association Business Meeting
Friday October 2nd
08.00 Session VI – Neurology and COVID-19 Symposium
09.00 Session VII – Neuroinfection
10.20 Session VIII – Virtual Poster Tour II
11.00 Session IX – Neurosurgery and Cerebrovascular
14.00 Session X – Noel Callaghan Guest Lecture
15.00 Session XI – General Interest
16.15 Announcement of Prizes
16.45 Close of Meeting
vINA Meeting Programme
-
O1 13.00 Hypometabolism in the brain and retina occurs in multiple sclerosis and is a marker of disease severity: a study using novel non-invasive imaging techniques.
Murphy OC, Kalaitzidis G, Vasileiou E, Filippatou A, Lambe J, Sotirchos ES, Dewey B, Liu Y, Prince JL, Lu H, Calabresi PA, Saidha S.O2 13.13 Preliminary validation of static posturography as a disability outcome measure in progressive multiple sclerosis.
Yap SM, Etzelmueller M, O’Keeffe C, Gaughan M, Reilly RB, McGuigan C.
O3 13.26 Lymphocyte response in standard and extended interval dosing of natalizumab
Rafee S, Kennelly L, McGuigan C.O4 13.39 Early factors associated with later conversion to multiple sclerosis in patients presenting with isolated myelitis
Murphy OC, Mukharesh L, Salazar-Camelo A, Pardo CA Newsome SD. -
O5 14.00 Everolimus as a precision medicine for epilepsy due to pathogenic variants in DEPDC5
Kearney H, M. Doyle P. Moloney, R. Carton, K. Benson, G.L. Cavalleri, N. DelantyO6 14.13 Identification of potential surgical epilepsy cases in a non-specialist centre. What happened to those 18 patients previously identified in 2015? Are we doing any better?
Noor S, Flynn C.O7 14.26 An Audit of Medical Admissions for Seizures in a Model Three Hospital in Ireland.
Bradley M, Nursing M, Chalissery A.O8 14.39 Prescribing Patterns of Medicinal Cannabis for Epilepsy in the Republic of Ireland
Gilligan M, Widdess-Walsh P.O9 14.52 Audit of the in-patient referral system for adult EEGs at St Vincent’s University Hospital.
O’Brien E, Bjerke A, Connolly S.O10 15.05 Association between social deprivation and the incidence of first seizures, new diagnosis of epilepsy and seizure mimics.
Maloney EM, Corcoran P, Costello DJ, O'Reilly EJ. -
Tour A 15.40 Multiple Sclerosis Tour B 15.50 Neurovascular Tour C 15.40 Neurogenetics Tour D 15.50 Cognitive Impairment -
O11 16.00 Seeing the Woods for the Trees? Dementia with Lewy Bodies presenting as Posterior Cortical Atrophy
Kelly MJ, O'Dowd, SO12 16.13 The Utilisation of 18-FDG PET Brain Imaging in the Neurocognitive Clinic of a Tertiary Referral Unit and its Impact on Clinical Care
Wrigley S, Liddy s, Killeen R, Kinsella J.
O13 16.26 Four more years? The price of patience in early primary lateral sclerosis
Finegan E, Chipika RH, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, McLaughlin RL, Hardiman O, Bede P.
O14 16.39 Between a Rock and a Hard Place.
Chaity D, Kelly E, Alexander M, Austin N, O’ Byrne J, Pastores G, Merwick A, Saif M, O’ Dowd S. -
17.00 Irish Neurological Association Business Meeting -
08.00 Round Table Discussion - COVID-19 and its neurological manifestations Prof. Patrick Mallon, UCD Professor of Microbial Diseases and Associate Dean, Research & Innovation, University College Dublin
Dr. Patricia McNamara, Locum Consultant Neurologist, The National Hospital for Neurology and Neurosurgery, Queen Square and Northwick Park Hospital.
Dr. Maria Gaughan, Aspire MS Clinical and Research Fellow, St. Vincent's University Hospital, Dublin -
O15 09.15 Brain Morphometric Changes in Non-Cirrhotic Chronic Hepatitis C Virus Infection
Ferguson D, Strahan O, Bergin C, McKiernan S, Norris S, Doherty CP.O16 09.28 Clinical and radiological features of twenty patients diagnosed with MOG demyelinating syndrome.
Gaughan M, McGuigan C.017 09.41 Clinical improvement of progressive multifocal leukoencephalopathy following pembrolizumab infusion.
Togher Z, Fullam S, Gunko A, Tubridy N, Feeney E, McGuigan C.O18 09.54 Single centre analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period.
Ferguson D, Wrigley S, Purcell E, Keane S, McGinn B, O’Malley S, Lynch B, Crowe CO19 10.07 The many faces of neurosarcoidosis: a clinico-radiological case series
Moloney P, Llamas Y, O’Rourke K, Smyth S, Lynch T. -
Tour E 10.20 Movement Disorders Tour F 10.30 Clinical Neurophysiology/Neuromuscular Tour G 10.20 Neuroinfections Tour H 10.30 Toxic / Metabolic and General Interest -
O20 11.00 Strokes in the young: TOAST classification and main risk factors.
Kennedy J, Rafee S, Lockhart A, O Connor R, McGuigan C.O21 11.13 A rare neurological complication of undiagnosed hereditary haemorrhagic telangiectasia.
Monaghan B, Gilligan M, Ni Choileain O, Lavin M, Lee M, O’ Brien E, McAdam B, Power S, Costelloe L.O22 11.26 von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity and their relationship with cerebral micro-embolic status in patients with carotid stenosis
Murphy SJX ; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O’Neill D; Harbison JA; Madhavan P; O’Neill SM; Colgan MP; O’Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJHO23 11.39 Audit of road traffic accidents and whiplash injuries in medical legal practice
Phillips J.O24 11.52 A descriptive study of fractures of the cervical spine managed by the Neurosurgery Department at Cork University Hospital
Mulcahy C, Ming-Sheng Lim, O’Sullivan M.O25 12.05 Silicone allergy mimicking shunt infection
Leer M, Simms HNO26 12.18 Management, complications and neurological outcomes of aneurysmal subarachnoid haemorrhage in elderly patients
Cheng PH, Simms HN, Abouharb A. -
Noel Callaghan Guest Lecture 14.00 The revolutionary Rx for PD that almost got away: the levodopa story
Prof. Stanley Fahn,
H. Houston Merritt Professor of Neurology and Director Center for PD and Other Movement Disorders. Department of Neurology Columbia University Medical Center. The Neurological Institute. New York, New York. -
O27 15.00 Inherited cerebellar ataxias: 5-year experience of the National Ataxia Clinic in Ireland
Bogdanova-Mihaylova P, Hebert J, Moran S, Murphy M, Ward D, Walsh RA, Murphy SM.O28 15.13 Undiagnosed Neuropathology In Fallers: Findings from a 10-year Autopsy Series.
Fearon C, Hunt C, Brett FM, Lorigan J, Beausang A, Cryan J, Farrell MA.O29 15.26 The initial experience of a deep brain stimulation service in Ireland
Laffan A, Walsh R, Lynch T.O30 15.39 Dysphagia: Junior Doctors' Knowledge and Perceptions.
Ryan M, Trimble G, Dynan J, Hughes S. -
Poster Categories
-
A1 Alemtuzumab-related thyroid disease in people with multiple sclerosis is associated with age and brainstem phenotype at disease onset Yap SM, Dillon M, Crowley RK, McGuigan C. A2 Co-incident Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia (SPG4) – a Case Report. Boucher J, Counihan T. A3 New diagnoses of Multiple Sclerosis in Sligo University Hospital - a 1 year audit. Joyce E, Waters Á, McPartland G, Mansoor S, Murphy K, Kelly S. A4 ‘Reportedly’…: An Analysis of the Coverage of Multiple Sclerosis in the Irish Print Media. O'Donnell M, Redmond J. A5 PLEX in pregnancy: A Viable Option for Treatment of Resistant MS. [Withdrawn] O'Flynn O, Reynolds A, Kinirons P, Higgins J, Merwick A. A6 Numb chin syndrome as a multiple sclerosis mimic in a patient with disseminated malignancy Smyth M, Hennessy, M. A7 Diversity in CNS autoimmune encephalitides: Multiple antibodies; differing clinical phenotypes. Lockhart A, Boers P. -
B1 The change in management of Vertebrobasilar Strokes in an Irish Model 3 Hospital; a comparison of 2 time-periods. Fullam S, Togher Z, Crowley P, Cotter P. B2 Neurovascular conflict causing nervus imtermedius neuralgia. Hannon C, Hurley A, O’Dowd S. B3 Evaluation of the lipids and follow up after ischemic stroke- a retrospective cohort study in Cork University Hospital. Nikola C, Khashab A, Gunko A, Ryan A. B4 Atherosclerotic stroke and neutrophil lymphocyte ratios in a young stroke cohort. Tierney C, Rafee S, McGuigan C. B5 Fingolimod Increases Regulatory T Cells in a Mouse Model of Permanent Brain Ischaemia. Malone K, Diaz Diaz A, Shearer J, Moore AC, Waeber C. B6 Now you see me, now you don’t! – Rapid spontaneous resolution of aqueductal obstruction.
Togher Z, Walsh MC, Fullam S, O’Riordan C, Cotter P, Crowley P. -
C1 An unusual presentation and basal ganglia calcification: is there a link?
Rafee S, Dudley A, Tubridy N. C2 Variant Ataxia Telangiectasia with a cavernoma and extensive white matter signal abnormalities.
Buckley C, Byrne D, Llamas Osorio Y, Kavanagh E, Lynch T. C3 First report of simultaneous haematological and immunological involvement in DeSanto-Shinawi Syndrome.
Darcy S, Bogdanova-Mihaylova P, Tuohy E, Niall Conlon N, Murphy SM. C4 A multi-disciplinary approach to the management of classical ataxia-telangiectasia for the adult neurologist.
McKenna MC, Cox F, Roche S, McDonald I, Fahy R, Conlon N, Edgar JD, Redmond J. C5 Genes or proteins: clinching the diagnosis in an era of genetic variants of uncertain significance.
Menon, PJ, Bogdanova-Mihaylova P, Walsh RA, Taylor M, Murphy SM. C6 Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids (HDLS) caused by a mutation in the CSF1R gene.
O’Donnell L, Murphy K, Buckley C, Farrell MA, Fearon C, Llamas Y, Lynch T. -
D1 A Survey of the Use of CSF Analysis in the Investigation and Diagnosis of Dementia Disorders in Munster. Gleeson K, Fitzgerald P, Costello D, Munteanu T, Kinirons P. D2 Severe Amnestic Syndrome as a consequence of Theophylline Toxicity. Joyce E, Olszewska DA, Counihan T. D3 Rapidly progressive haemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome and posterior reversible encephalopathy syndrome. Lyons S, Bartels HC , O’Malley S, Asad M, O’Meara Y, Ni Ainle F, Geary M, O’Rourke K D4 Acute confusion and large frontal mass.
Rafee S, Killeen R, Tubridy N. -
E1 An audit of advanced care planning in outpatients with idiopathic Parkinson’s
Disease.McKenna MC, Erica Walsh, David Bradley. E2 Sleep, Depression, and Quality of Life in Parkinson’s Disease: An Investigation Using a Combination of Subjective and Objective Sleep Assessment Methods.
Mulryan P, Affonso S, O’Keeffe GW, Sullivan AM. E3 An Assessment of Sleep Quality in an Irish Parkinson’s Disease Cohort Using a Combination of Subjective and Objective Measures.
Mulryan P, Affonso S, O’Keeffe GW, Sullivan AM. E4 A Relapsing Ataxia with GQ1b Antibodies in CSF but not serum; Further Evidence for anti-ganglioside mediated CNS disease? Lockhart A, Mills J, Boers P. -
F1 Distal axonopathy in paraplegin deficiency: peripheral neuropathy is not a common feature in SPG7-associated spastic ataxia. Bogdanova-Mihaylova P, Gorman C, Alexander M, McHugh J, Richard Walsh R, Murphy SM. F2 Retrospective analysis of Neurophysiological and MRI findings in a cohort referred for Brachial Plexopathy. Gunko A, Haider S, Brian McNamara B. F3 Lucky man: a case of musicogenic epilepsy. Lyons S, Khalil M, Williams J, Widdess-Walsh P, O’Rourke K. F4 Bilateral Forearm Compartment Syndrome as a presenting feature of McArdle Disease. Gailani G, Bermingham N, Ryan A. F5 When You Cannot ‘Keep Your Chin Up’: An Unusual Case of Head Drop.
O’Donnell M, Hunt I, MC, Armstrong C, Flynn C, Leonard N, Cryan J, Langan Y, Redmond J. F6 Mitochondrial cytopathy masquerading as an inflammatory myopathy. Fives C, Jansen M, Blakely EL, Gorman GS, Taylor RW, McNamara B, Sweeney B, Bermingham N. -
G1 Hypervirulent Klebsiella Pneumoniae presenting with Community Acquired Meningitis – A Case Report from Ireland.
Bradley M, O’Murchadha L, Tacheva A, Morris B, Gileece A, Tun T, Chalissery A. G2 Quadriplegia following Herpes Zoster. Gilligan M, Doyle M, Widdess-Walsh P. G3 NMDA encephalitis, Cryptococcal Meningitis and Immunocompetency- The Chicken and the Eggs. Hunt I, McKenna MC, N, O’Rourke A, Langan Y, Conlon N, Merry C, Redmond J, Hutchinson S. G4 COVID-19 encephalopathy mimicking autoimmune encephalitis in a patient with mild COVID-19 infection. Gaughan M, Connolly S, O’Riordan S, McGuigan C, Tubridy N, Kinsella J. G5 Progressive Multifocal Leukoencephalopathy – Immune Reconstitution Inflammatory Syndrome (PML-IRIS): a diagnostic muddle. Almobaied M, Chaila E, Gadir A, Birmingham N, O’Connell S. G6 The story continues: narcolepsy spectrum occurring several years post-H1N1 vaccination in young Irish siblings. Ferguson D, Slattery L, Lynch B, O’Malley S, Crowe C. G7 Progressive Multifocal Leucoencephalopathy as a tumour mimic in an apparently immunocompetent man. Fives C, Jansen M, Wyse G, Mohammed W, Healy L, Bermingham N. G8 Patients’ experiences of virtual outpatient clinics in a Neurology Department during the COVID-19 pandemic. McKenna MC, Al Hinai M, Bradley D, Doran E, Hunt I,Hutchinson S, Langan Y, O’Rourke D, Qasem R, Redmond J, Stanila RL, Troy E, Doherty CP. G9 Cytomegalovirus – Not So (H)armless.
Togher Z, Higgins E, Gunko A, Doyle M, Fullam S, Tubridy N, Connolly S, Feeney E, McGuigan C. -
H1 Perceptions of medicinal cannabis among patients with epilepsy.
Gilligan M, G. Burke, White M, Delanty N, P. Widdess-Walsh. H2 Food for thought; D-lactic acidosis, a rare cause of recurrent encephalopathy.
Asad M, Smyth S, Leyden J. H3 An evaluation of optimal tutorial methodologies for neurology teaching at an undergraduate level.
Togher Z, Fullam S, Callanan I, Kearney H, Tubridy N. H4 Observations on a decade of electronic neurology referrals.
Togher Z, Fullam S, Tubridy N.
